Boothbay Fund Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.39M | Sell |
63,566
-9,100
| -13% | -$486K | 0.07% | 267 |
|
|
2025
Q1 | $2.94M | Buy |
+72,666
| New | +$2.94M | 0.08% | 263 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1295 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1387 |
|
|
2023
Q4 | – | Sell |
-40,280
| Closed | -$2.04M | – | 1456 |
|
|
2023
Q3 | $2.04M | Buy |
+40,280
| New | +$2.04M | 0.05% | 394 |
|
|
2023
Q2 | – | Sell |
-10,035
| Closed | -$384K | – | 1533 |
|
|
2023
Q1 | $384K | Buy |
+10,035
| New | +$384K | 0.01% | 1171 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1714 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1920 |
|
|
2020
Q1 | – | Sell |
-10,000
| Closed | -$222K | – | 733 |
|
|
2019
Q4 | $222K | Buy |
+10,000
| New | +$222K | 0.02% | 580 |
|